Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone

Conditions

• HIV
• Contraception

Interventions

• DRUG: TFV IVR
• DRUG: TFV/LNG IVR
• OTHER: Placebo IVR

Sponsor

CONRAD